Strategic Capital Fund Management Acquires $13.5 Million Data Center
GREENWICH, Conn.–(BUSINESS WIRE)–Strategic Capital Fund Management’s data center real estate division, Strategic Data Center Fund…
GREENWICH, Conn.–(BUSINESS WIRE)–Strategic Capital Fund Management’s data center real estate division, Strategic Data Center Fund…
Decentralized compute network Block Digital is expanding the number of computer servers using renewable energy…
SAN FRANCISCO–(BUSINESS WIRE)–#DOD–TurbineOne, the frontline perception company, was awarded a Small Business Innovation Research (SBIR)…
Insight’s fourth annual corporate social responsibility report reflects the organization’s continued resiliency, innovation and commitment…
COLUMBUS, Ind.–(BUSINESS WIRE)–Today, Cummins Inc. (NYSE: CMI) announced Jennifer Rumsey, its President and Chief Operating…
BERKELEY HEIGHTS, N.J.–(BUSINESS WIRE)–Hayward Holdings, Inc. (NYSE: HAYW) a global designer, manufacturer, and marketer of…
Homebuilder’s latest community offers new townhomes in a popular San Diego County location, affordably priced…
DALLAS–(BUSINESS WIRE)–Generational Capital Markets, Member FINRA/SIPC and a leading mergers and acquisitions advisor for privately-held…
Study did not meet primary endpoint nor notable secondary endpoints – no benefit observed in…
NEW YORK and LONDON, Feb. 11, 2022 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX),…
WILMINGTON, Del., Feb. 11, 2022 (GLOBE NEWSWIRE) — Prelude Therapeutics Inc. (NASDAQ: PRLD), a clinical-stage…
SEATTLE and CAMBRIDGE, United Kingdom, Feb. 11, 2022 (GLOBE NEWSWIRE) — Eliem Therapeutics, Inc. (Nasdaq:…
Immunocore to present at the SVB Leerink Global Healthcare Conference (OXFORDSHIRE, England & CONSHOHOCKEN, Penn….
Company prioritizing industry-leading clinical-stage programs, AXO-AAV-GM1 and AXO-AAV-GM2, the first potential disease-modifying therapies for GM1…
BRANFORD, Conn., Feb. 11, 2022 (GLOBE NEWSWIRE) — IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell…
BOSTON and LOUISVILLE, Ky., Feb. 11, 2022 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc. (Nasdaq: TALS),…
Q4 Net Sales Growth 4.3%; Core Sales Growth 5.8% Q4 Diluted EPS $0.22; Normalized Diluted…
Record annual revenue of $20.4 billion Record annual net income of $3.0 billion Record annual…
BAINBRIDGE, Ga.–(BUSINESS WIRE)–Danimer Scientific (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics…
TAMPA, Fla.–(BUSINESS WIRE)–Syniverse®, the “world’s most connected company®” and a premier global technology provider of…